The complete blood count device market size has grown strongly in recent years. It will grow from $4.33 billion in 2025 to $4.58 billion in 2026 at a compound annual growth rate (CAGR) of 6%. The growth in the historic period can be attributed to expansion of clinical diagnostic testing volumes, increased hospital laboratory automation, growing burden of chronic diseases, availability of standardized blood testing protocols, rising demand for routine health screenings.
The complete blood count device market size is expected to see strong growth in the next few years. It will grow to $5.76 billion in 2030 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to increasing adoption of decentralized diagnostics, rising investments in smart laboratory infrastructure, growing demand for rapid diagnostic results, expansion of preventive healthcare testing, continuous advancements in hematology technology. Major trends in the forecast period include increasing adoption of automated hematology analyzers, rising demand for point-of-care cbc devices, growing integration of ai-based diagnostics, expansion of high-throughput laboratory systems, enhanced focus on diagnostic accuracy and speed.
The growing prevalence of blood disorders is expected to drive the growth of the complete blood count (CBC) device market in the coming years. Blood disorders are conditions that impair the production, function, or structure of blood cells, leading to compromised blood function. The rise in these disorders is associated with the increasing incidence of lifestyle-related diseases, where poor diet, physical inactivity, and stress contribute to conditions such as anemia and clotting abnormalities. Complete blood count devices assist in diagnosing blood disorders by analyzing key blood components and detecting abnormalities, enabling healthcare professionals to identify clotting issues and provide timely, precise treatment. For example, in May 2024, the Canadian Cancer Society reported that 4,100 individuals in Canada were diagnosed with multiple myeloma, a type of blood cancer, and 1,750 individuals died from the disease. Consequently, the increasing prevalence of blood disorders is propelling the expansion of the CBC device market.
Companies in the CBC device market are developing advanced products such as compact hematology analyzers to deliver faster, more accurate, and cost-effective solutions for point-of-care testing. These portable, user-friendly devices provide complete blood count results quickly and with minimal sample volume, enhancing diagnostic accuracy, efficiency, and ease of use. For instance, in June 2024, HORIBA, a Japan-based analytical and measurement technology company, launched the Yumizen H550E and H500E hematology analyzers. These compact analyzers integrate erythrocyte sedimentation rate (ESR) testing with CBC and 5-part differential (DIFF) analysis, using HORIBA’s patented CoRA (correlated rouleaux analysis) technology to provide comprehensive results from whole blood samples in just 60 seconds.
In February 2024, Sysmex Corporation, a Japan-based hematology analyzer manufacturer, partnered with CellaVision AB to advance hematology through AI-driven digital cell morphology. The collaboration aims to improve efficiency, precision, and standardization in hematology testing by combining Sysmex’s expertise with CellaVision’s imaging technologies, enabling more accurate diagnoses and better clinical outcomes. CellaVision AB is a Sweden-based provider of digital hematology microscopy solutions.
Major companies operating in the complete blood count device market are Abbott Laboratories, Siemens Healthineers, Mindray Medical International Limited, Beckman Coulter Inc., Sysmex Corporation, Horiba Ltd., Nihon Kohden Corporation, Agappe Diagnostics Ltd., Trivitron Healthcare Pvt. Ltd., HemoCue AB, EKF Diagnostics Holdings plc, Erba Mannheim, Boule Diagnostics AB, Biosystems S.A., Diatron MI Zrt., Labtron Equipment Ltd., Microlab Instruments Co. Pvt. Ltd., URIT Medical Electronic Co. Ltd., Roche Diagnostics, Ortho Clinical Diagnostics, BioSystems Diagnostics Pvt. Ltd., Drew Scientific (subsidiary of EKF), Analyticon Biotechnologies GmbH, Rayto Life and Analytical Sciences Co. Ltd.
North America was the largest region in the complete blood count device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the complete blood count device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the complete blood count device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the complete blood count device market by increasing costs of imported sensors, microfluidic components, lasers, reagents, and electronic control units used in automated and point-of-care analyzers. Diagnostic laboratories and hospitals in North America and Europe are most affected due to reliance on imported high-precision components, while Asia-Pacific faces cost pressures on device exports. These tariffs are raising procurement costs and slowing equipment replacement cycles. At the same time, they are supporting domestic manufacturing, regional supply chain localization, and increased innovation in cost-efficient diagnostic device design.
The complete blood count device market research report is one of a series of new reports that provides complete blood count device market statistics, including complete blood count device industry global market size, regional shares, competitors with a complete blood count device market share, detailed complete blood count device market segments, market trends and opportunities, and any further data you may need to thrive in the complete blood count device industry. This complete blood count device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A complete blood count (CBC) device is a medical tool used to conduct a complete blood count, a common laboratory test that measures the levels and characteristics of different blood components. This device automates the blood analysis process, providing accurate and quick results that help healthcare professionals make informed diagnostic and treatment decisions.
The main categories of complete blood count devices include automated blood count analyzers, manual blood count analyzers, point-of-care testing devices, and hematology analyzers. Automated blood count analyzers are sophisticated instruments that utilize various technologies to quickly and precisely count and classify blood cells, improving efficiency and minimizing manual errors in clinical laboratories. These devices perform tests such as white blood cell (WBC) count, WBC differential count, red blood cell (RBC) count, hematocrit (HCT), hemoglobin (HGB), platelet count, mean platelet volume (MPV), mean corpuscular hemoglobin (MCH), and others. They employ technologies like impedance, laser-based methods, flow cytometry, and microscopy. Distribution occurs through channels such as direct sales, online platforms, third-party distributors, and retail pharmacies, with end-users including hospitals, diagnostic labs, research centers, and more.
The complete blood count (CBC) device market consists of sales of automated hematology analyzers, point-of-care CBC devices, reagents and consumables. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The complete blood count device market size is expected to see strong growth in the next few years. It will grow to $5.76 billion in 2030 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to increasing adoption of decentralized diagnostics, rising investments in smart laboratory infrastructure, growing demand for rapid diagnostic results, expansion of preventive healthcare testing, continuous advancements in hematology technology. Major trends in the forecast period include increasing adoption of automated hematology analyzers, rising demand for point-of-care cbc devices, growing integration of ai-based diagnostics, expansion of high-throughput laboratory systems, enhanced focus on diagnostic accuracy and speed.
The growing prevalence of blood disorders is expected to drive the growth of the complete blood count (CBC) device market in the coming years. Blood disorders are conditions that impair the production, function, or structure of blood cells, leading to compromised blood function. The rise in these disorders is associated with the increasing incidence of lifestyle-related diseases, where poor diet, physical inactivity, and stress contribute to conditions such as anemia and clotting abnormalities. Complete blood count devices assist in diagnosing blood disorders by analyzing key blood components and detecting abnormalities, enabling healthcare professionals to identify clotting issues and provide timely, precise treatment. For example, in May 2024, the Canadian Cancer Society reported that 4,100 individuals in Canada were diagnosed with multiple myeloma, a type of blood cancer, and 1,750 individuals died from the disease. Consequently, the increasing prevalence of blood disorders is propelling the expansion of the CBC device market.
Companies in the CBC device market are developing advanced products such as compact hematology analyzers to deliver faster, more accurate, and cost-effective solutions for point-of-care testing. These portable, user-friendly devices provide complete blood count results quickly and with minimal sample volume, enhancing diagnostic accuracy, efficiency, and ease of use. For instance, in June 2024, HORIBA, a Japan-based analytical and measurement technology company, launched the Yumizen H550E and H500E hematology analyzers. These compact analyzers integrate erythrocyte sedimentation rate (ESR) testing with CBC and 5-part differential (DIFF) analysis, using HORIBA’s patented CoRA (correlated rouleaux analysis) technology to provide comprehensive results from whole blood samples in just 60 seconds.
In February 2024, Sysmex Corporation, a Japan-based hematology analyzer manufacturer, partnered with CellaVision AB to advance hematology through AI-driven digital cell morphology. The collaboration aims to improve efficiency, precision, and standardization in hematology testing by combining Sysmex’s expertise with CellaVision’s imaging technologies, enabling more accurate diagnoses and better clinical outcomes. CellaVision AB is a Sweden-based provider of digital hematology microscopy solutions.
Major companies operating in the complete blood count device market are Abbott Laboratories, Siemens Healthineers, Mindray Medical International Limited, Beckman Coulter Inc., Sysmex Corporation, Horiba Ltd., Nihon Kohden Corporation, Agappe Diagnostics Ltd., Trivitron Healthcare Pvt. Ltd., HemoCue AB, EKF Diagnostics Holdings plc, Erba Mannheim, Boule Diagnostics AB, Biosystems S.A., Diatron MI Zrt., Labtron Equipment Ltd., Microlab Instruments Co. Pvt. Ltd., URIT Medical Electronic Co. Ltd., Roche Diagnostics, Ortho Clinical Diagnostics, BioSystems Diagnostics Pvt. Ltd., Drew Scientific (subsidiary of EKF), Analyticon Biotechnologies GmbH, Rayto Life and Analytical Sciences Co. Ltd.
North America was the largest region in the complete blood count device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the complete blood count device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the complete blood count device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the complete blood count device market by increasing costs of imported sensors, microfluidic components, lasers, reagents, and electronic control units used in automated and point-of-care analyzers. Diagnostic laboratories and hospitals in North America and Europe are most affected due to reliance on imported high-precision components, while Asia-Pacific faces cost pressures on device exports. These tariffs are raising procurement costs and slowing equipment replacement cycles. At the same time, they are supporting domestic manufacturing, regional supply chain localization, and increased innovation in cost-efficient diagnostic device design.
The complete blood count device market research report is one of a series of new reports that provides complete blood count device market statistics, including complete blood count device industry global market size, regional shares, competitors with a complete blood count device market share, detailed complete blood count device market segments, market trends and opportunities, and any further data you may need to thrive in the complete blood count device industry. This complete blood count device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A complete blood count (CBC) device is a medical tool used to conduct a complete blood count, a common laboratory test that measures the levels and characteristics of different blood components. This device automates the blood analysis process, providing accurate and quick results that help healthcare professionals make informed diagnostic and treatment decisions.
The main categories of complete blood count devices include automated blood count analyzers, manual blood count analyzers, point-of-care testing devices, and hematology analyzers. Automated blood count analyzers are sophisticated instruments that utilize various technologies to quickly and precisely count and classify blood cells, improving efficiency and minimizing manual errors in clinical laboratories. These devices perform tests such as white blood cell (WBC) count, WBC differential count, red blood cell (RBC) count, hematocrit (HCT), hemoglobin (HGB), platelet count, mean platelet volume (MPV), mean corpuscular hemoglobin (MCH), and others. They employ technologies like impedance, laser-based methods, flow cytometry, and microscopy. Distribution occurs through channels such as direct sales, online platforms, third-party distributors, and retail pharmacies, with end-users including hospitals, diagnostic labs, research centers, and more.
The complete blood count (CBC) device market consists of sales of automated hematology analyzers, point-of-care CBC devices, reagents and consumables. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Complete Blood Count Device Market Characteristics
3. Complete Blood Count Device Market Supply Chain Analysis
4. Global Complete Blood Count Device Market Trends and Strategies
5. Complete Blood Count Device Market Analysis of End Use Industries
7. Global Complete Blood Count Device Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Complete Blood Count Device Total Addressable Market (TAM) Analysis for the Market
9. Complete Blood Count Device Market Segmentation
10. Complete Blood Count Device Market Regional and Country Analysis
11. Asia-Pacific Complete Blood Count Device Market
12. China Complete Blood Count Device Market
13. India Complete Blood Count Device Market
14. Japan Complete Blood Count Device Market
15. Australia Complete Blood Count Device Market
16. Indonesia Complete Blood Count Device Market
17. South Korea Complete Blood Count Device Market
18. Taiwan Complete Blood Count Device Market
19. South East Asia Complete Blood Count Device Market
20. Western Europe Complete Blood Count Device Market
21. UK Complete Blood Count Device Market
22. Germany Complete Blood Count Device Market
23. France Complete Blood Count Device Market
24. Italy Complete Blood Count Device Market
25. Spain Complete Blood Count Device Market
26. Eastern Europe Complete Blood Count Device Market
27. Russia Complete Blood Count Device Market
28. North America Complete Blood Count Device Market
29. USA Complete Blood Count Device Market
30. Canada Complete Blood Count Device Market
31. South America Complete Blood Count Device Market
32. Brazil Complete Blood Count Device Market
33. Middle East Complete Blood Count Device Market
34. Africa Complete Blood Count Device Market
36. Complete Blood Count Device Market Competitive Landscape and Company Profiles
37. Complete Blood Count Device Market Other Major and Innovative Companies
40. Complete Blood Count Device Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Complete Blood Count Device Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses complete blood count device market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for complete blood count device? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The complete blood count device market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Device Type: Automated Blood Count Analyzers; Manual Blood Count Analyzers; Point-Of-Care Testing Devices; Hematology Analyzers2) By Test Type: White Blood Cell Count (WBC Or Leukocyte Count); White Blood Cell (WBC) Differential Count; Red Blood Cell Count (RBC Or Erythrocyte Count); Hematocrit (Hct); Hemoglobin (Hbg); Platelet Count; Mean Platelet Volume (MPV); Mean Corpuscular Hemoglobin (MCH); Other Test Types
3) By Technology: Impedance Technology; Laser-Based Technology; Flow Cytometry; Microscopy
4) By Distribution Channel: Direct Sales; Online Sales; Third-Party Distributors; Laboratory Equipment Suppliers
5) By End-User: Hospital; Diagnostic Laboratories; Research Institutes; Other End-Users
Subsegments:
1) By Automated Blood Count Analyzers: 3-Part Differential Analyzers; 5-Part Differential Analyzers; 6-Part And Above Differential Analyzers; Integrated Hematology Systems; High-Throughput Lab Analyzers2) By Manual Blood Count Analyzers: Hemocytometers; Microscopes For Manual Differential; Manual Cell Counters; Staining Kits And Reagents
3) By Point-of-Care Testing Devices: Portable Hematology Analyzers; Handheld Complete Blood Count (CBC) Devices; Fingerstick Blood Test Devices; Rapid Diagnostic Complete Blood Count (CBC) Kits
4) By Hematology Analyzers: Low-Volume Hematology Analyzers; Mid-Volume Hematology Analyzers; High-Volume Hematology Analyzers; Veterinary Hematology Analyzers; Reagent-Free Analyzers
Companies Mentioned: Abbott Laboratories; Siemens Healthineers; Mindray Medical International Limited; Beckman Coulter Inc.; Sysmex Corporation; Horiba Ltd.; Nihon Kohden Corporation; Agappe Diagnostics Ltd.; Trivitron Healthcare Pvt. Ltd.; HemoCue AB; EKF Diagnostics Holdings plc; Erba Mannheim; Boule Diagnostics AB; Biosystems S.A.; Diatron MI Zrt.; Labtron Equipment Ltd.; Microlab Instruments Co. Pvt. Ltd.; URIT Medical Electronic Co. Ltd.; Roche Diagnostics; Ortho Clinical Diagnostics; BioSystems Diagnostics Pvt. Ltd.; Drew Scientific (subsidiary of EKF); Analyticon Biotechnologies GmbH; Rayto Life and Analytical Sciences Co. Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Complete Blood Count Device market report include:- Abbott Laboratories
- Siemens Healthineers
- Mindray Medical International Limited
- Beckman Coulter Inc.
- Sysmex Corporation
- Horiba Ltd.
- Nihon Kohden Corporation
- Agappe Diagnostics Ltd.
- Trivitron Healthcare Pvt. Ltd.
- HemoCue AB
- EKF Diagnostics Holdings plc
- Erba Mannheim
- Boule Diagnostics AB
- Biosystems S.A.
- Diatron MI Zrt.
- Labtron Equipment Ltd.
- Microlab Instruments Co. Pvt. Ltd.
- URIT Medical Electronic Co. Ltd.
- Roche Diagnostics
- Ortho Clinical Diagnostics
- BioSystems Diagnostics Pvt. Ltd.
- Drew Scientific (subsidiary of EKF)
- Analyticon Biotechnologies GmbH
- Rayto Life and Analytical Sciences Co. Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 4.58 Billion |
| Forecasted Market Value ( USD | $ 5.76 Billion |
| Compound Annual Growth Rate | 5.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 25 |
